Allurion Technologies Inc. (ALUR)
OTCMKTS · Delayed Price · Currency is USD
0.8000
0.00 (0.00%)
At close: May 27, 2026
Allurion Technologies Revenue
Allurion Technologies had revenue of $2.95M in the quarter ending March 31, 2026, a decrease of -47.19%. This brings the company's revenue in the last twelve months to $12.60M, down -55.49% year-over-year. In the year 2025, Allurion Technologies had annual revenue of $15.23M, down -52.57%.
Revenue (ttm)
12.60M
Revenue Growth
-55.49%
P/S Ratio
0.95
Revenue / Employee
314.93K
Employees
41
Market Cap
12.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.23M | -16.88M | -52.57% |
| Dec 31, 2024 | 32.11M | -21.36M | -39.94% |
| Dec 31, 2023 | 53.47M | -10.74M | -16.73% |
| Dec 31, 2022 | 64.21M | 25.97M | 67.91% |
| Dec 31, 2021 | 38.24M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| QHSLab | 2.78M |
| Kelyniam Global | 2.67M |
| BioElectronics | 1.61M |
| PetVivo Holdings | 1.11M |
| Guided Therapeutics | 767.00K |
| CS Diagnostics | 204.00K |
| Holdco Nuvo Group D.G | 176.00K |
| ALR Technologies SG | 25.54K |
Allurion Technologies News
- 12 days ago - Allurion Technologies Quarterly report: Q1 2026 - Filings
- 5 weeks ago - Allurion Technologies treats first commercial patients in the U.S. - TheFly
- 5 weeks ago - Allurion Treats First Commercial Patients in the United States, Marking Major Milestone - Business Wire
- 2 months ago - Allurion Technologies Annual report: Q4 2025 - Filings
- 2 months ago - Allurion Technologies appeals NYSE decision to initiate delisting proceedings - TheFly
- 2 months ago - Allurion Advances Plan to Regain Listing Compliance - Business Wire
- 2 months ago - Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy - Business Wire
- 2 months ago - NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - Business Wire